Australian Stroke and Heart Research Accelerator (ASHRA)

Transforming the field of cardiovascular research in Australia.

ASHRA is a powerful partnership of leading research, clinical and academic institutes and industry working together to fundamentally transform Australia’s global competitiveness in heart disease and stroke research: accelerating the pace of translation and commercialisation of cardiovascular research to deliver health and economic outcomes for the Australian community and reduce the burden and health inequities of cardiovascular disease

KEY STATISTICS

Research Portfolio

22 Projects

Diseases

5 Heart Failure, 11 CAD, 2 Multiple CVD, 4 Stroke

Innovations

6 Therapeutic, 8 Device, 4 Digital, 3 Screening, 1 Cohort Register

Researchers

110 Researchers

 31 Early and Mid-Career Researchers

Collaborators

8 Core Academic Partners

12 Industry Partners

47 Associate Partners

Core academic partners

Monash University
The University of Sydney
Victor Chang Cardiac Research Institute
The George Institute for Global Health
The University of New South Wales
Australian National University
The University of Melbourne
Menzies School of Health Research

Delivering research with impact sooner

ASHRA is the Cardiovascular Disease centre under the Targeted Translation Research Accelerator (TTRA) program, delivered by MTPConnect for the Medical Research Future Fund.